SCHEMBL735096

SCHEMBL735096

CNC1(c2nc(C)cs2)CC=C(c2[nH]c3ccccc3c2C)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.36
OPRL1 P41146 2/20 0.36
KDM4E B2RXH2 2/20 0.34
TSHR P16473 1/20 0.33
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
POLB P06746 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
OGFRL1 Q5TC84 1/20 0.32
AHR P35869 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
ADRB2 P07550 1/20 0.30
HTR1A P08908 1/20 0.30
MAPT P10636 1/20 0.30
HTR2A P28223 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL733122 0.81 OPRM1 (0.45) OPRM1OPRL1KDM4ECYP11B1CYP11B2
SCHEMBL734178 0.69 OPRM1 (0.42) OPRM1OPRL1KDM4ECYP11B1CYP11B2
SCHEMBL734169 0.69 OPRM1 (0.57) OPRM1OPRL1OGFRL1
SCHEMBL734065 0.66 CNR2 (0.38) MAPT
SCHEMBL735918 0.64 OPRM1 (0.47) OPRM1OPRL1KDM4ECYP11B1CYP11B2
SCHEMBL735507 0.63 OPRM1 (0.57) OPRM1OPRL1OGFRL1HTR2AHTR2C
SCHEMBL736103 0.63 OPRM1 (0.49) OPRM1OPRL1TSHROGFRL1AHR
SCHEMBL3395044 0.62 AHR (0.46) KDM4ECYP11B1CYP11B2POLBAHR
SCHEMBL19225658 0.62 CNR2 (0.53) KDM4E
SCHEMBL734668 0.61 OPRM1 (0.45) OPRM1OPRL1KDM4ETSHRCYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
EP-2044016-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2009-04-08 EP disclosed
WO-2008009415-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1- AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 OPRM1 1029/4885OPRL1 1562/4885KDM4E 2643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.